Introduction
Acetylcholine (ACh) is an important neurotransmitter critical for learning and memory (Hagan and Morris, 1988) , and loss of cholinergic function contributes to the profound learning impairments and memory deficits associated with age-related dementia and Alzheimer's disease (Bartus et al., 1982; Kasa et al., 1997) . Evidence supporting a role for ACh in cognitive processes includes the findings that muscarinic acetylcholine receptor (mAChR) antagonists impair memory in animals (Buresova et al., 1986) and humans (Drachman and Leavitt, 1974) , and that mAChR activation facilitates the long-term synaptic plasticity thought to be the physiological substrate of learning and memory (Blitzer et al., 1990; Burgard and Sarvey, 1990; Hasselmo and Barkai, 1995; Ovsepian et al., 2004) .
A number of studies have examined the influence of ACh and cholinergic agonists on pyramidal neuron excitability in the cortex. Studies using intracellular current-clamp recordings have generally found mAChR activation to be excitatory, producing depolarizing responses in neurons and facilitating action potential generation (Krnjevic et al., 1971; McCormick and Prince, 1985, 1986; Schwindt et al., 1988; Halliwell, 1989; Andrade, 1991; Metherate et al., 1992; Wang and McCormick, 1993; Gloveli et al., 1999; Egorov et al., 2002 Egorov et al., , 2003 . These direct excitatory effects have been attributed to mAChR-mediated inhibition of potassium conductances (Krnjevic et al., 1971; Schwindt et al., 1988; McCormick and Williamson, 1989; McCormick, 1990; Nishikawa et al., 1994) , although more recent data suggest that ACh may also increase activation of a nonselective cation conductance (Andrade, 1991; Andrade, 1996, 1998; Klink and Alonso, 1997; Shalinsky et al., 2002; Egorov et al., 2003) .
In a minority of studies, inhibitory actions of ACh on neocortical pyramidal neurons have been reported (McCormick and Prince, 1985, 1986; Halliwell, 1989; Müller and Singer, 1989; Bandrowski et al., 2001; Yamamoto et al., 2002) . Experiments conducted in vitro found that pressure applications of high concentrations of exogenous ACh (1-50 mM) can hyperpolarize pyramidal neurons (McCormick and Prince, 1985, 1986) . Because responses were found to be sensitive to classical inhibitors of synaptic transmission [low external Ca 2ϩ or tetrodotoxin (TTX)] and to blockers of GABA A channels (picrotoxin or bicuculline), the inhibitory actions of ACh were attributed to increased GABA transmission after mAChR-mediated excitation of interneurons (McCormick and Prince, 1985, 1986) . Similar observations suggested that a GABAergic mechanism was responsible for the mAChR-mediated inhibition reported by Bandrowski et al. (2001) in rat auditory cortex in vitro and by Müller and Singer (1989) in cat visual cortex in vivo.
Because these previous studies typically used high concentrations of muscarinic agonists (1-100 mM) (Krnjevic et al., 1971; McCormick and Prince, 1985, 1986; Schwindt et al., 1988; McCormick and Williamson, 1989; Müller and Singer, 1989; Wang and McCormick, 1993; Gloveli et al., 1999; Egorov et al., 2002 Egorov et al., , 2003 or prolonged, tonic mAChR stimulation (Schwindt et al., 1988; Halliwell, 1989; Yamamoto et al., 2002) , the resulting data do not describe the actions of transient mAChR activation, as is likely to happen during synaptic release of ACh (Metherate et al., 1992; Bandrowski et al., 2001) . In this study, we use rapid and focal application of relatively low concentrations of mAChR agonists to show that transient mAChR activation generates strong and direct inhibition of neocortical pyramidal neurons by inducing calcium release from internal stores and subsequent activation of an SK-type calcium-activated potassium conductance.
Materials and Methods
Recordings were made from visually identified layer 5 pyramidal neurons in coronal brain slices (300 m thick) of somatosensory cortex prepared from 3-to 5-week-old or 10-week-old Wistar rats according to methods approved by the Australian National University. Slices were perfused with a solution [artificial CSF (aCSF) ] containing the following (in mM): 125 NaCl, 25 NaHCO 3 , 3 KCl, 1.25 NaH 2 PO 4 , 2 CaCl 2 , 1 MgCl 2 , and 25 glucose (at 35°C, bubbled with 95% O 2 /5% CO 2 ). Whole-cell recording pipettes (5-7 M⍀) contained the following (in mM): 135 K-gluconate or K-methylsulfate, 7 NaCl, 2 MgCl 2 , 10 HEPES, 2 Na 2 ATP, and 0.3 NaGTP, pH 7.2 with KOH. No significant differences were observed in cholinergic responses recorded in cells recorded with K-gluconate or K-methylsulfate solutions. For extracellular recordings, recording pipettes were filled with regular aCSF and placed near the axon initial segment. Data were acquired using a BVC-700 amplifier (Dagan, Minneapolis, MN) and a Macintosh computer (Apple Computers, Cupertino, CA) running AxoGraph 4.9 (Molecular Devices, Union City, CA). Whole-cell series resistance was generally between 10 and 25 M⍀ and was maximally compensated. Membrane potentials were corrected for the liquid junction potential (Ϫ12 mV for K-gluconate pipettes; Ϫ8 mV for K-MSO 4 pipettes). ACh-mediated hyperpolarizations were measured relative to the resting membrane potential immediately before drug application. The magnitude of ACh-induced hyperpolarizations during firing was measured from the minimum membrane potential achieved during interspike afterhyperpolarizations. For transient activation of mAChR agonists, patch pipettes were filled with 100 M carbachol or ACh dissolved in aCSF, connected to a Picospritzer 3 (Parker Instrumentation, Chicago, IL), and brief applications of carbachol or ACh were applied close to the soma of recorded neurons (within 20 m) using a pressure of 10 psi, unless otherwise indicated. To estimate the time course of solution exchange, 20 ms applications of intracellular pipette saline were delivered to neurons voltage clamped at Ϫ70 mV. In these control experiments, the 10 -90% rise time of the generated inward currents was 12 Ϯ 1 ms (n ϭ 3). All ACh and carbachol applications to a given neuron were generated with the puff pipette positioned at the same location and using the same application duration, unless otherwise indicated. During bath application, drugs were washed in for 5 min before recording the effect of drug application and subsequently washed out up to 0.5 h. In the absence of pharmacological manipulations, responses to repeated focal ACh applications did not change during the duration of whole-cell recordings (up to 1 h) when interleaved by 5 s somatic depolarizations sufficient to generate action potential firing (data not shown). Drugs were obtained from Sigma (St. Louis, MO). GABA A receptor antagonists were coapplied with kynurenic acid (2 mM). For imaging experiments, cells were filled with 100 M Oregon Green BAPTA-6F (OGB6F) (Invitrogen, Carlsbad, CA), and line scans (10 or 100 Hz temporal resolution) were made across the longitudinal axis of the soma using a confocal microscope (LSM 510; Zeiss, Oberkochen, Germany) . Raw data were background subtracted, and the change in florescence relative to the resting fluorescence (⌬F/F ) was calculated over a 400 ms baseline period before ACh application. Data are presented as mean Ϯ SEM. Statistical analysis used either the Student's t test (two tailed, paired or unpaired) or an ANOVA with a Tukey's post hoc test, for paired or unpaired data, as appropriate.
Results

Transient muscarinic receptor activation hyperpolarizes cortical pyramidal neurons
To examine the effect of transient mAChR activation, we focally applied ACh (100 M) or carbachol (100 M) near the soma of visually identified layer 5 pyramidal neurons (Fig. 1 A) . In all cells tested (Ͼ200), transient mAChR activation produced a delayed hyperpolarizing response from rest ( Fig. 1 B, C) . Hyperpolarizing responses to 1-s-long applications of ACh (mean amplitude, Ϫ4.6 Ϯ 0.5 mV; n ϭ 21) or carbachol (mean amplitude, Ϫ4.8 Ϯ 0.3 mV; n ϭ 30) were not significantly different ( p ϭ 0.6), and data were therefore pooled. A more detailed comparison of hyperpolarizing responses to 1-s-long ACh and carbachol applications is presented in Table 1 . For the combined dataset (n ϭ 51), ACh or carbachol application (1 s) produced a biphasic response consisting of a delayed hyperpolarization followed by, or superimposed on, a slower depolarization. Hyperpolarizing responses had a mean latency of 344 Ϯ 19 ms, a rise time of 208 Ϯ 19 ms, an amplitude of Ϫ4.7 Ϯ 0.3 mV, and half-widths of 568 Ϯ 55 ms (n ϭ 51). Two methods were used to confirm that hyperpolarizing responses to ACh or carbachol application were attributable to mAChR activation. First, to test that focal applications themselves do not induce hyperpolarizations, normal aCSF was focally applied to four neurons for 1 s periods. No significant change in membrane potential was observed in these cells (mean change in membrane potential during application of aCSF alone was Ϫ0.6 Ϯ 0.2 mV; n ϭ 4; p ϭ 0.2; data not shown). Second, bath application of the muscarinic receptor antagonist atropine (10 M) completely and irreversibly blocked hyperpolarizing responses in six of six neurons tested (Fig. 1 D) . In baseline conditions, carbachol application (1 s) generated responses of Ϫ3.4 Ϯ 0.6 mV. After bath application of atropine (5 min), the mean change in membrane potential at a time corresponding to the peak of the hyperpolarization in baseline conditions was ϩ0.2 Ϯ 0.2 mV (n ϭ 6; p Ͻ 0.01).
The biphasic response to transient mAChR activation described above contrasts with the depolarizing responses typically observed during tonic mAChR activation (Schwindt et al., 1988; Halliwell, 1989; Haj-Dahmane and Andrade, 1996) . To determine the relationship between the duration of mAChR activation and the peak amplitude of hyperpolarizing and depolarizing responses, ACh was applied to a separate group of neurons for durations ranging from 5 to 1000 ms (Fig. 1 E) . The resulting "duration-response" curves for the hyperpolarizing and depolarizing components of the response were fit with exponential functions (Fig. 1 F) . This experiment indicated that hyperpolarizing and depolarizing responses reached steady state during ACh applications of Ͻ1 s duration. Exponential fits to these data demonstrate that, relative to hyperpolarizing responses ( ϭ 19 Ϯ 2 ms), depolarizing responses ( ϭ 139 Ϯ 37 ms) require approximately seven times longer periods of ACh exposure to generate maximum response amplitude (n ϭ 10; p Ͻ 0.05). These data suggest that briefer periods of mAChR activation will favor the generation of hyperpolarizing responses over depolarization.
To determine whether hyperpolarizing responses to transient mAChR activation is specific to neurons from younger (3-to 5-week-old) animals, we focally applied ACh (50 ms) to pyramidal neurons in slices obtained from 10-week-old rats. As was observed in neurons from younger animals, transient mAChR activation produced delayed and long-lasting hyperpolarizing responses in neurons from fully mature animals (Fig. 1G) . The mean amplitude of hyperpolarization produced by ACh application in neurons from 10-week-old rats (Ϫ5.6 Ϯ 0.6 mV; n ϭ 6) was not significantly different from that produced by similar ACh applications in neurons from younger animals (mean response in younger animals was Ϫ5.0 Ϯ 0.6 mV; n ϭ 10; p ϭ 0.5), indicating that hyperpolarizing responses to transient mAChR activation also occur in adult animals.
Finally, because mAChRs require intracellular signal transduction via G-protein-linked cascades, it is possible that our use of whole-cell recording could modify normal cholinergic signaling. To confirm that mAChR-induced hyperpolarizations do not result from intracellular changes attributable to whole-cell recording, we made extracellular recordings from identified layer 5 pyramidal neurons while neurons were driven to fire action potentials spontaneously by increased extracellular potassium (6 mM) and bath application of the glutamate receptor agonist kainate (200 nM). Under these conditions, in six of six neurons, focal application of ACh (20 ms) to the soma produced a prolonged inhibition of action potential firing (Fig. 1 H) . For these experiments, the mean duration of inhibition was 1640 Ϯ 270 ms, and the instantaneous spike frequency (ISF) was reduced from 13.8 Ϯ 2.7 to 0.6 Ϯ 0.1 Hz (n ϭ 6; p Ͻ 0.01).
Pharmacology of mAChR-mediated hyperpolarization
Muscarinic receptors have been broadly classified into two distinct families based on their coupling to intracellular messengers. Members of the M 1 -type family (M 1 , M 3 , and M 5 ) are generally associated with G q signaling and phosphatidylinositol turnover. In contrast, members of the M 2 -type family (M 2 and M 4 ) are generally linked via G i to cAMP production. To determine the receptor family responsible for mediating ACh-induced hyperpolarizations, we focally applied ACh (1 s) before and after exposing slices to selective muscarinic antagonists. Bath application (5 min) of the M 1 -type-selective antagonist pirenzepine (PZP) (500 nM) completely blocked ACh-induced hyperpolarizing responses (n ϭ 6) ( Fig. 2 A, C) . In control conditions, ACh applications for 1 s produced hyperpolarizing responses of Ϫ5.2 Ϯ 1.0 mV and delayed depolarizations of 4.7 Ϯ 0.8 mV (n ϭ 6). After PZP application, hyperpolarizing responses were no longer observed, with the mean change in membrane potential at a time corresponding to the peak hyperpolarization in control conditions being ϩ1.6 Ϯ 0.7 mV (n ϭ 6; p Ͻ 0.01). Similarly, the delayed depolarizing phase was significantly reduced by PZP, being reduced to only ϩ1.2 Ϯ 0.4 mV at a time corresponding to the peak depolarization in control conditions (n ϭ 6; p Ͻ 0.01). Conversely, in a separate group of neurons, bath application of the M 2 -selective antagonist methoctramine (MCT) (500 nM; 5 min) had no effect on hyperpolarizing responses to 1-s-long applications of ACh (n ϭ 6) ( Fig. 2 B, D) . In these neurons, the peak amplitude of hyperpolarizing and depolarizing responses in control were Ϫ4.1 Ϯ 0.7 and 5.0 Ϯ 1.3 mV, respectively. After the bath application of MCT, hyperpolarizing responses to ACh were of identical amplitude (Ϫ4.1 Ϯ 0.5 mV), whereas peak depolarizing responses were slightly, but not significantly, larger, with the mean depolarization in MCT being 7.1 Ϯ 1.8 mV (n ϭ 6; p ϭ 0.7) (Fig. 2 D) .
The data above indicate that both hyperpolarizing and depolarizing responses to brief (1 s) ACh applications require M 1 -type receptor activation. Furthermore, the finding that atropine and PZP completely block hyperpolarizing ACh responses, whereas carbachol mimics the effect of ACh, strongly suggest that nicotinic receptors play little, if any, role in their generation. To compare the depolarization generated by brief ACh applications with the depolarization commonly observed during tonic mAChR activation, we bath applied carbachol (10 M) to control slices and slices continuously exposed to either PZP (500 nM; n ϭ 6) or MCT (500 nM; n ϭ 5). In control neurons, bath application of carbachol (5 min) depolarized neurons by 4.9 Ϯ 0.3 mV (n ϭ 15; (5, 10, 20, 50, 100, 200, 500 , and 1000 ms). F, Plot of the mean peak hyperpolarizing and depolarizing responses produced by variable durations of ACh exposure (n ϭ 10). Dashed lines indicate exponential fits to the averaged data from 10 neurons. The time constants of the averaged data were 18 ms for hyperpolarizing responses and 121 ms for depolarizing responses. G, Hyperpolarizing responses to ACh (50 ms) recorded in pyramidal neurons in somatosensory slices from adult (10-week-old) rats (top), and a summary graph comparing responses in younger and older animals (bottom). H, Extracellular recordings of responses to focal ACh application (20 ms) in a neuron before and after exposure to increased extracellular potassium (6 mM) and kainate (200 nM). Below is a plot of the instantaneous spike frequency (ISI) for this neuron showing the ACh-induced inhibition. p Ͻ 0.0001), an amount similar to the peak amplitude of the depolarizing phase of responses to transient (1 s) mAChR activation with ACh (4.9 Ϯ 0.7 mV; n ϭ 12, data combined from baseline responses in the separate PZP and MCT experiments above). In neurons exposed to pirenzepine, bath application of carbachol (5 min) produced no significant depolarization (mean change in membrane potential was ϩ0.3 Ϯ 0.4 mV; n ϭ 6; p ϭ 0.5) (Fig. 2C ), a result that was significantly different from the depolarization observed during 1-s-long applications of ACh in control conditions ( p Ͻ 0.001). In contrast, in the presence of MCT, bath-applied carbachol (5 min) depolarized neurons by 6.2 Ϯ 1.0 mV (n ϭ 5; p Ͻ 0.01) (Fig. 2 D) , an amount not significantly different from the depolarization observed by transient (1 s) mAChR activation in control conditions (n ϭ 17; p ϭ 0.3). Together, these data suggest that the transient depolarization observed during focal ACh application is qualitatively and quantitatively similar to the depolarization observed during tonic carbachol application.
Previous studies demonstrating ACh-mediated hyperpolarization of neocortical pyramidal neurons during application of high concentrations of ACh (ϳ10 mM) have suggested that the inhibitory actions of ACh are mediated by GABAergic synaptic transmission (McCormick and Prince, 1985, 1986) . To test whether GABA mediates the ACh-induced hyperpolarizations described above, we focally applied ACh (1 s) in the continual presence of antagonists of GABA A and GABA B receptors. The presence of any of three GABA A -specific antagonists, picrotoxin (100 M; n ϭ 7), bicuculline methiodide (20 M; n ϭ 3), or 2-(3-carboxypropyl)-3-amino-6-(4-methoxyphenyl)pyridazinium bromide (SR 95531) (10 M; n ϭ 6), delivered at concentrations sufficient to block GABAergic signaling, failed to block ACh-mediated hyperpolarizations (Fig. 3) . Similarly, the presence of the GABA B receptor antagonist (2S)-3-[[(15)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl](phenylmethyl)phosphinic acid (CGP 55845) (1 M; n ϭ 6) had no effect on ACh-mediated hyperpolarizing responses (Fig. 3) . No significant differences were observed in the mean amplitudes of hyperpolarizing responses generated in control conditions (mean response, Ϫ4.6 Ϯ 0.5 mV; n ϭ 21) (Table 1 ) and responses generated in the presence of GABAergic antagonists (ANOVA; p ϭ 0.68) (Fig.  3B) . The mean peak responses in GABA antagonists were Ϫ3.4 Ϯ 0.8 mV (picrotoxin), Ϫ3.9 Ϯ 0.5 mV (bicuculline), Ϫ4.2 Ϯ 0.6 mV (SR 95531), and Ϫ5.0 Ϯ 0.8 mV (CGP 55845). Together, these data demonstrate that ACh-induced hyperpolarizations require activation of M 1 -type muscarinic receptors but do not involve increases in GABAergic synaptic transmission.
Hyperpolarizing responses are facilitated by calcium entry through voltage-gated calcium channels
To explore the impact of neuronal firing on transient cholinergic signaling, we compared responses to transient mAChR activation generated at resting potentials and during trains of action potentials. When ACh was repeatedly applied (five applications of 20 ms duration at 8 s intervals) to neurons at resting potentials (Ϫ78 Ϯ 1 mV; n ϭ 9), initial responses were quite large, with subsequent responses showing rapid reduction in amplitude (Fig.   4 A) . Compared with the initial hyperpolarization, responses to applications 2 through 5 were reduced by 73 Ϯ 9, 80 Ϯ 6, 87 Ϯ 6, and 86 Ϯ 5%, respectively (n ϭ 9; p Ͻ 0.001).
In the same neurons, ACh applications were repeated during periods of repetitive action potential firing generated by somatic current injection (Fig. 4 A, C) . Under these conditions, responses to the first application of ACh were significantly more hyperpolarizing than were initial responses generated at rest (Ϫ4.8 Ϯ 0.6 mV compared with Ϫ3.4 Ϯ 0.3 mV at rest; n ϭ 9; p Ͻ 0.05). Furthermore, membrane depolarization prevented response rundown during repeated applications, with responses being reduced by only 2 Ϯ 10, Ϫ3 Ϯ 10, 3 Ϯ 11, and 13 Ϯ 12% for applications 2 through 5, respectively (n ϭ 9; p ϭ 0.32). Additional experiments revealed that brief periods of action potential firing (4 or 5 s), delivered immediately before a test application of ACh or carbachol, prevented response rundown to repeated ACh applications at the resting potential (data not shown; see also Fig. 7C below) . This procedure was used throughout the experiments described in this manuscript to obtain reproducible responses to repeated ACh or carbachol applications.
To determine whether action potentials themselves are necessary to prevent response rundown, in a separate group of neurons, we blocked action potentials by including TTX (1 M) in the aCSF while delivering repetitive focal applications of ACh (20 ms; five applications at 8 s intervals). In the presence of TTX, and with membrane potentials adjusted to Ϫ60 mV with current injection to mimic action potential threshold, responses to focal ACh applications 2 through 5 were reduced by 67 Ϯ 8, 75 Ϯ 6, 71 Ϯ 6, and 82 Ϯ 7%, respectively (n ϭ 11; p Ͻ 0.0001), amounts that were similar to those observed at resting potentials without TTX present (Fig. 4 B, C) . Although these data suggest that TTXsensitive action potentials are required to reduce rundown, when the same neurons were further depolarized by strong current injection (600 -900 pA) to membrane potentials above Ϫ50 mV (mean, Ϫ42 Ϯ 3 mV), responses 2 through 5 were reduced by only 9 Ϯ 3, 6 Ϯ 4, 7 Ϯ 5, and 10 Ϯ 5% (n ϭ 11; p Ͻ 0.05) (Fig.  4 B, C) , indicating that depolarization in the absence of action potentials can prevent response rundown.
Another potential mechanism by which depolarization might facilitate mAChR-mediated responses is through the activation of voltage-gated calcium channels (VGCCs) and subsequent increases in intracellular calcium. To determine whether VGCCs play a role in promoting hyperpolarizing responses to mAChR activation, in a subset of neurons previously exposed to TTX (n ϭ 10), we bath applied the broad-spectrum VGCC antagonist cadmium chloride (200 M, 5 min exposure) while repeatedly applying ACh (five applications of 20 ms at 8 s intervals). In the presence of both TTX and cadmium, and with strong somatic depolarization to membrane potentials above Ϫ50 (mean membrane potential, Ϫ41 Ϯ 2 mV), responses 2 through 5 were reduced by 52 Ϯ 10, 46 Ϯ 4, 57 Ϯ 5, and 65 Ϯ 4%, respectively (n ϭ 10; p Ͻ 0.0001) (Fig. 4 B, C) . In five of these neurons, we washed out cadmium for 20 min and observed a partial reversal of the effects of cadmium. In these neurons, responses 2 through 5 were reduced by 15 Ϯ 9, 11 Ϯ 7, 24 Ϯ 8, and 23 Ϯ 10%, respectively (n ϭ 5; p ϭ 0.1). To examine the influence of VGCC on cholinergic hyperpolarizing responses in neurons at rest, in a separate group of neurons not exposed to TTX, we bath applied cadmium (200 M; 5 min). In five neurons, baseline responses to ACh (40 ms) recorded in control conditions (mean amplitude, Ϫ3.4 Ϯ 0.5 mV) were blocked after 5 min exposure to cadmium (Fig. 4 D) . In the presence of cadmium, the mean response amplitude was reduced to Ϫ0.4 Ϯ 0.4 mV (n ϭ 5; p Ͻ 0.01 when compared with baseline responses). Removal of cadmium from the bath partially rescued the cholinergic response in four of these neurons (mean response after wash, Ϫ1.7 Ϯ 0.9 mV; n ϭ 5). Together, the data above demonstrate that it is calcium entry through VGCCs, rather than action potentials per se, that is required to prevent the rundown of cholinergic hyperpolarizing responses.
Ionic mechanism of mAChR-mediated hyperpolarizations
The data above demonstrate that transient exposure to ACh produces a direct inhibitory effect on cortical pyramidal neurons that is not mediated by the synaptic release of GABA. Furthermore, the data above demonstrating that cadmium, but not TTX, antagonizes cholinergic signaling suggests that intracellular calcium may play a role in generating hyperpolarizing responses to ACh. To confirm that intracellular calcium is important for mAChR signaling, we filled patch pipettes with an internal solution including the calcium-chelating agent BAPTA (10 mM). In six of six neurons, the presence of BAPTA completely blocked hyperpolarizing responses to 1-slong applications of ACh, with the mean change in membrane potential after ACh application being ϩ1.3 Ϯ 0.2 mV within 5 min after obtaining a whole-cell recording (Fig. 5B) . Because the presence of BAPTA in the recording pipette blocked responses immediately, it was impossible to compare responses before and after BAPTA application. As an added control, in four additional neurons, we made whole-cell recordings of hyperpolarizing responses with pipettes filled with regular intracellular solution (no BAPTA) before repatching with a BAPTA-containing pipette (Fig.  5A) . In all four neurons, hyperpolarizing responses to ACh that were observed when pipettes were filled with regular intracellular solution (mean response was Ϫ4.2 Ϯ 0.7 mV) were completely blocked when BAPTA was introduced during repatching (mean response at times matching peak hyperpolarization in first patches was ϩ0.6 Ϯ 0.3 mV). In a separate group of four neurons, we repatched neurons with regular pipette saline without BAPTA. In this control group, hyperpolarizing responses to ACh after repatching were similar to the mAChR responses observed during the first patch recording (mean response to ACh after repatching was Ϫ3.6 Ϯ 1.0 mV; n ϭ 4; p ϭ 0.52; data not shown). These data demonstrate a necessity for free intracellular calcium in the generation of hyperpolarizing responses to ACh.
We next determined the reversal potential for ACh responses by transiently an effect that was partially reversed after 20 min wash in regular aCSF (red trace). C, Summary graph comparing the amplitude of hyperpolarizing responses for each of five ACh applications in control cells at rest and when depolarized (circles; n ϭ 9), in a separate group of neurons exposed to 1 M TTX at Ϫ60 mV and during strong depolarization (triangles; n ϭ 11), and a subset of neurons transiently exposed to cadmium (diamonds; n ϭ 10; n ϭ 5 for wash). D, Bath application of cadmium chloride (200 M) in the absence of TTX reversibly eliminates the hyperpolarizing response to a 40 ms ACh application at resting potentials.
applying ACh to neurons while manipulating the membrane potential by somatic current injection (Fig. 5C ). The mean reversal potential for ACh responses was Ϫ93 Ϯ 1 mV (n ϭ 10), a value close to the expected reversal potential for potassium (Ϫ98 mV), suggesting that mAChR-mediated hyperpolarizations result from activation of a potassium conductance. Indeed, mAChR activation was associated with a significant increase in membrane conductance (Fig. 5D) . In a subset of neurons, hyperpolarizing pulses (Ϫ200 pA, 15 ms duration, at 15 Hz) were generated repeatedly while ACh (n ϭ 8) or carbachol (n ϭ 4) was focally applied to neurons, and the hyperpolarization generated from these negative current pulses was compared between different phases of the response (mean of three consecutive events immediately before drug application, at the peak of the hyperpolarizing response, and 1.5 s after the hyperpolarizing response were compared). In these neurons, mAChR activation produced an increase in membrane conductance of 31 Ϯ 5% during the peak of the hyperpolarizing response (n ϭ 12; p Ͻ 0.05). Conversely, at 1.5 s after the drug application, during the depolarizing phase of the response, whole-cell conductance was slightly, but significantly, decreased by 10 Ϯ 3% ( p Ͻ 0.001).
Because hyperpolarizing responses to ACh result from activation of a membrane conductance that reverses near the equilibrium potential for potassium, and, given their dependency on intracellular calcium, we tested the hypothesis that mAChR activation hyperpolarizes layer 5 pyramidal neurons by activating calcium-activated potassium channels. Bath application of apamin (50 or 100 nM; 5 min exposure), an antagonist of SK-type calcium-activated channels, completely and irreversibly blocked all hyperpolarizing responses to focal ACh application (40 ms) (Fig. 5 E, F ) . In baseline conditions, ACh application generated hyperpolarizing responses of Ϫ4.8 Ϯ 0.3 mV. After apamin application for 5 min, ACh-mediated hyperpolarizations were completely abolished, with the mean change in membrane potential being ϩ1.2 Ϯ 0.4 mV at a time corresponding to the peak hyperpolarization in baseline conditions (n ϭ 6; p Ͻ 0.05). Another substance known to block SK-type channels nonspecifically is the GABA A channel antagonist bicuculline methiodide (Johnson and Seutin, 1997) . In contrast to the lack of effect seen with low concentrations (20 M) of bicuculline, bath application of bicuculline at a higher concentration (100 M) for 5 min reversibly blocked hyperpolarizing responses to mAChR activation (Fig.  5G) . In baseline conditions, 1-s-long applications of ACh generated hyperpolarizations of Ϫ3.1 Ϯ 0.4 mV. After a 5 min bath application of bicuculline, the mean change in membrane potential at the time of peak hyperpolarization in baseline conditions was 0.0 Ϯ 0.2 mV (n ϭ 10; p Ͻ 0.001). After 10 -15 min of wash 4 M; n ϭ 4). C, Responses to a 40 ms application of carbachol (100 M; top) from different starting potentials generated by somatic current injection (bottom). Right, A plot of peak response versus starting potential indicates a reversal potential of Ϫ94 mV. D, ACh-induced hyperpolarizations are associated with an increased membrane conductance. The membrane response to repetitive current injections is shown during the focal application of ACh (1 s). Thick dashed lines indicate the amplitude of membrane responses to somatic current steps in baseline conditions (shown again during the depolarizing phase of the Ach response for comparison). Thin dotted lines show the amplitude of responses to current injection during the peak of the ACh-induced hyperpolarization. To the right are enlarged traces of individual hyperpolarizing pulses generated before (1), during (2), and after (3) in regular aCSF, responses returned to Ϫ2.6 Ϯ 0.6 mV. Together, these data demonstrate that ACh hyperpolarizes neocortical pyramidal neurons through the activation of SK-type potassium channels.
mAChR-dependent intracellular calcium signaling
The data presented above indicate that mAChR activation in pyramidal neurons triggers an increase in intracellular calcium concentration. To observe this directly, we loaded neurons with the low-affinity calcium-sensitive dye OGB6F (100 M) and focally applied ACh while measuring somatic fluorescence with confocal microscopy (Fig. 6) (supplemental videos 1, 2 , available at www.jneurosci.org as supplemental material). Hyperpolarizing responses to focal ACh applications (5-20 ms) were associated with increases in intracellular calcium, as indicated by increases in fluorescence during line scans through the longitudinal axis of the soma (Fig. 6 A) . Consistent with the facilitatory action of neuronal depolarization described above (Fig. 4 A-C) , the amplitude of ACh-induced increases in fluorescence was 51 Ϯ 20% larger when ACh was applied during periods of action potential firing (n ϭ 5; p Ͻ 0.01) (Fig. 6 B) . When responses generated at resting potentials were analyzed (17 trials in 5 neurons), a statistically significant correlation was observed between peak ⌬F/F and the amplitude of the corresponding hyperpolarizing voltage response (n ϭ 21; p Ͻ 0.01) (Fig. 6C) . During the imaging experiments described above, short applications of ACh were used to limit the depolarizing phase of the ACh response. To compare calcium signaling during hyperpolarizing and depolarizing responses, we imaged calcium transients during 1-s-long ACh applications (Fig. 6 D, E) . To limit movement artifacts during 1-s-long ACh applications, pipettes were positioned ϳ30 m from the soma, and pressure was reduced to ϳ5 psi. Under these conditions, ACh application produced biphasic, hyperpolarizing then depolarizing responses. The peak hyperpolarization in these responses was Ϫ2.8 Ϯ 0.4 mV, whereas the peak depolarization was 5.3 Ϯ 0.9 mV (Fig. 6 D) . To compare calcium signaling during the two phases, we measured ⌬F/F at the peak of the hyperpolarizing and depolarizing responses (Fig. 6 D, E) . During the peak of the hyperpolarizing response, ⌬F/F was 1.05 Ϯ 0.09. Conversely, ⌬F/F at the peak of depolarizing responses was significantly less (n ϭ 4; p Ͻ 0.001), being very close to zero (mean ⌬F/F at peak depolarization was 0.02 Ϯ 0.01; n ϭ 4). Our finding that internal calcium levels are not increased during the depolarizing phase of ACh responses is consistent with previous data showing that bath application of carbachol alone does not produce calcium signals in these neurons (Larkum et al., 2003) .
Because the increases in intracellular calcium described above were coincident with hyperpolarization but not depolarization of the membrane potential, they are unlikely to be attributable to activation of VGCCs. Therefore, we hypothesized that mAChR activation induces the release of calcium from intracellular stores. To test for this, we emptied intracellular calcium stores with bath-applied cyclopiazonic acid (CPA) (30 M). Five minutes of exposure to CPA completely blocked ACh-induced hyperpolarizing responses (n ϭ 6) (Fig. 7A) . In control conditions, brief applications of ACh (20 ms) produced a 4.1 Ϯ 0.6 mV hyperpolarization of the membrane potential. After CPA application, all hyperpolarizing responses were absent, revealing a small depolarization of 0.9 Ϯ 0.2 mV (n ϭ 6; p Ͻ 0.001) (Fig. 7B) .
Calcium release from intracellular stores can be mediated by two ligand-gated channels in the endoplasmic reticulum: ryanodine-sensitive receptors and IP 3 -sensitive receptors. To test for a role of ryanodine receptors in mAChR signaling, we repeatedly applied ACh (40 ms duration, 15 s intervals) while bath applying ryanodine to interfere with ryanodine receptor signaling (Fig. 7C) . Bath application of ryanodine (20 M; 10 min) led Figure 6 . Calcium-imaging experiments demonstrate a rise in internal calcium that is correlated with the timing and magnitude of hyperpolarizing responses to ACh. A, Voltage (top) and optical (⌬F/F; bottom) responses of a pyramidal neuron to a 5 ms application of ACh at rest (left) and during a train of action potentials generated by somatic current injection (right). DC, Direct current. B, Summary data showing that the peak ⌬F/F is larger when generated during action potential (AP) firing (n ϭ 5). C, Plot of the correlation between peak ⌬F/F and the magnitude of the hyperpolarizing response from rest. Data are from multiple trials in five neurons experiencing ACh applications of 5-20 ms duration. D, The membrane response (top) and ⌬F/F measured from a line scan across the soma (bottom) during a 1-s-long application of ACh. Traces are the average of five consecutive ACh applications. The dotted line shows timing of peak hyperpolarization, and the dashed line demarks peak depolarization. E, Summary graph comparing ⌬F/F values at the peak of the depolarizing and hyperpolarizing phases of responses to 1-s-long applications of ACh (n ϭ 4).
to a rapid decreased in response amplitude by 95 Ϯ 2% (n ϭ 6; p Ͻ 0.01) (Fig. 7C) .
Although the ability of ryanodine to block mAChR-mediated hyperpolarizations is suggestive of a role for ryanodine receptors in gating ACh-induced calcium release, ryanodine and IP 3 receptors may share a common intracellular calcium store (Power and Sah, 2005) . If so, it is possible that activation of ryanodine receptors with bath-applied ryanodine may deplete IP 3 -sensitive calcium stores. To test the potential role of calcium release from IP 3 -sensitive stores, we patched neurons with pipettes filled with a solution containing the IP 3 receptor blocker heparin (2-3 mg/ ml) and measured hyperpolarizing responses to applications of ACh presented at 15 s intervals beginning immediately after the attainment of whole-cell recording (Fig. 7 D, E) . The addition of intracellular heparin produced a steady decrease in the peak amplitude and half-width of ACh-induced hyperpolarizing responses to 6 Ϯ 1 and 2 Ϯ 1% of their original amplitude, respectively, 10 min after the start of whole-cell recording (n ϭ 6; p Ͻ 0.001) (Fig. 7 D, E) .
To further test the role of ryanodine receptors, in separate experiments, we added the ryanodine receptor antagonist ruthenium red (40 M) to our pipette saline. Whereas intracellular ruthenium red produced no significant effect on the peak amplitude of responses (mean hyperpolarization after 10 min was 95 Ϯ 9% of the initial response; n ϭ 6; p ϭ 0.2) (Fig. 7D) , ruthenium red lead to a significant reduction in the half-width of hyperpolarizing responses by an average of 35 Ϯ 9% (n ϭ 6; p Ͻ 0.05) (Fig. 7E) . Together, these data suggest that calcium release after activation of IP 3 receptors is both necessary and sufficient to generate ACh hyperpolarizing responses, but activation of ryanodine receptors can prolong ACh-induced hyperpolarizations.
Interaction of tonic and transient mAChR signaling
The above data demonstrate that phasic mAChR activation hyperpolarizes and decreases the excitability of neocortical pyramidal neurons. Conversely, tonic mAChR stimulation with bathapplied agonists depolarizes cortical pyramidal neurons, leading to an increase in excitability and, in some cases, spontaneous action potential generation. To determine whether phasic and tonic mAChR signaling can coexist in individual pyramidal neurons, we focally applied ACh (100 M, 20 ms) before, during, and after bath application of carbachol (5 M; 5-10 min exposure). In five of six neurons that experienced subthreshold depolarization in carbachol, additional mAChR activation with focally applied ACh generated transient hyperpolarizing responses (Fig. 8 A) . In a second set of neurons (n ϭ 6), bath-applied carbachol (5 M) combined with periodic depolarizing current steps (1 s, ϳ300 pA, 0.1 Hz) produced enough depolarization to initiate spontaneous and sustained action potential generation, presumably by accelerating voltage-dependent depolarization by carbachol (McCormick and Prince, 1986; Haj-Dahmane and Andrade, 1996) . Under these circumstances, focal application of ACh continued to generate hyperpolarizing responses to inhibit action potential firing in 50% of neurons tested (n ϭ 3 of 6 neurons firing spontaneously in carbachol) (Fig. 8 B) . Together, these data demonstrate that transient increases in mAChR activation can inhibit layer 5 neurons even during periods of tonic mAChR activation that is sufficient to depolarize neurons to action potential threshold.
One situation that may lead to increases in ambient concentrations of cortical ACh is the use of acetylcholinesterase inhibitors (AChEIs). These drugs, which are commonly prescribed to combat the cognitive deficits associated with Alzheimer's disease, prevent the enzymatic breakdown of ACh in the brain. To investigate the impact of AChEIs, we focally applied ACh (1 s) to pyramidal neurons before and after bath application of eserine (Fig. 9A ). Eserine (2 M), an AChEI, moderately increased the mean amplitude of hyperpolarizing responses from Ϫ5.4 Ϯ 0.4 to Ϫ6.5 Ϯ 0.6 mV (n ϭ 17; p Ͻ 0.01) and prolonged their halfwidth from 471 Ϯ 46 to 598 Ϯ 48 ms (n ϭ 17; p Ͻ 0.05). More significantly, eserine dramatically enhanced depolarizing responses to ACh. In control conditions, 1-s-long ACh applications never induced spontaneous action potential generation on their own. When eserine was present, however, transient applications of ACh (1 s) produced sufficient depolarization to initiate action potential firing in 8 of the 17 neurons tested (47%; mean depolarization to threshold was 18 Ϯ 1 mV). In the remaining neurons, in which the depolarizing phase of the mAChR response remained subthreshold, eserine significantly increased the amplitude of the depolarizing responses from 3.6 Ϯ 0.4 to 5.8 Ϯ 0.8 mV (n ϭ 9; p Ͻ 0.05).
In contrast to the slight increase in the amplitude of inhibitory responses produced by eserine during single ACh applications, eserine reduced inhibition generated during repeated ACh applications (Fig. 9 B, C) . ACh was repeatedly applied to neurons during periods of suprathreshold somatic current injection (five applications at 8 s intervals) before and after the bath application of eserine (2 M). In control conditions, the initial application of ACh reduced the ISF to 0.8 Ϯ 0.09 Hz (n ϭ 9; mean baseline ISF was 8 Ϯ 1 Hz). The minimum ISFs generated by the subsequent four ACh applications were 1.2 Ϯ 0.07, 1.1 Ϯ 0.07, 1.1 Ϯ 0.08, and 1.1 Ϯ 0.07 Hz, respectively. When eserine was present, the baseline ISF generated by current injection increased to 13 Ϯ 1 Hz ( p Ͻ 0.001). Under these conditions, the initial application of ACh reduced the ISF to 0.7 Ϯ 0.05 Hz (n ϭ 9), a frequency similar to that observed in control conditions. Subsequent ACh applications, however, produced significantly less inhibition of action potential firing than in control conditions (Fig. 9 B, C) . In eserine, the minimum ISFs attained for applications 2 through 5 were 2.8 Ϯ 0.6, 3.6 Ϯ 0.8, 4.4 Ϯ 1.1, and 5.0 Ϯ 1.2 Hz, respectively (n ϭ 9; p Ͻ 0.05). The rundown of individual hyperpolarizing responses during action potential firing in eserine was similar to the rundown observed in control neurons at rest ( p ϭ 0.6) (Fig. 4C) , with responses 2 through 5 being reduced by 55 Ϯ 12, 91 Ϯ 28, 105 Ϯ 30, and 109 Ϯ 35%, respectively, when compared with the initial response (n ϭ 9; p Ͻ 0.0001). Additional experiments showed that the increase in rundown of ACh-induced inhibition in the presence of eserine was not attributable to an eserine-induced increase in the ISF, because control cells with similar ISFs to those observed in eserine showed no obvious rundown (Fig. 9D,E) . Together, these data demonstrate that AChEIs primarily enhance depolarization during single ACh applications but can decrease the inhibitory action of ACh when mAChRs are repeatedly activated during periods of intense somatic depolarization.
Discussion
The present study demonstrates, for the first time, that transient mAChR activation produces strong and direct inhibition of neocortical pyramidal neurons. Our data show that ACh, acting at M 1 -type mAChRs, induces calcium release from IP 3 -sensitive intracellular stores and subsequent activation of an apaminsensitive, calcium-activated potassium conductance in neocortical pyramidal neurons (supplemental Fig. 1 , available at www.jneurosci.org as supplemental material). This inhibition can be initiated by brief (Ն5 ms) ACh applications, can last for several seconds, and is strong enough to inhibit action potential generation even during periods of intense somatic depolarization. Remarkably, inhibitory responses to brief ACh applications were observed even during tonic mAChR activation that is sufficient to depolarize and drive action potential generation. Finally, we show that AChEIs enhance depolarization after transient mAChR activation but impede inhibition generated by repeated ACh applications. Together, these data demonstrate that ACh can directly inhibit cortical pyramidal neurons, and that this inhibition is less effective in the presence of AChEIs.
The direct SK-channel-dependent inhibitory action of transient mAChR activation in neocortical pyramidal neurons described here is similar to the inhibition generated in midbrain dopaminergic neurons after muscarinic (Fiorillo and Williams, 2000) or metabotropic glutamate (Fiorillo and Williams, 1998) receptor activation. Additionally, it is consistent with previous work showing that increases in intracellular IP 3 lead to the activation of calciumactivated potassium conductances, including an SK-type conductance, in pyramidal neurons in mouse prefrontal cortex (Stutzmann et al., 2003) and rat visual cortex (Yamada et al., 2004) . These previous data, together with our data from pyramidal neurons in rat somatosensory cortex, suggest that SK channel activation in response to the activation of G-proteincoupled receptors may be a generalized mechanism for inhibition in pyramidal neurons throughout the cortex. This cholinergic activation of apamin-sensitive SK channels contrasts with the well described block of the apamin-insensitive calcium-activated potassium channels underlying the slow afterhyperpolarization during tonic mACh activation in pyramidal neurons (Sah and Faber, 2002) and indicates that tonic and phasic mACh activation in the cortex are likely to have different functional roles.
Pharmacology of cholinergic signaling
Muscarinic transmission in the neocortex is critical for learning and memory (Winkler et al., 1995) , and muscarinic antagonists impair memory in animals and people (Drachman and Leavitt, 1974; Buresova et al., 1986) . The data presented here clearly support a role for muscarinic signaling in cortical processing. Our experiments using selective antagonists demonstrate that both the hyperpolarizing and depolarizing responses to ACh are mediated by M 1 -type mAChRs. Of the M 1 -familiy receptor subtypes (M 1 , M 3 , and M 5 ), M 1 receptors are by far the most abundant in the cerebral cortex, comprising up to 60% of all mAChRs expressed (Flynn et al., 1995) . Because M 3 and M 5 receptors are expressed at very low levels in the cortex, it is likely that the direct actions of ACh on cortical pyramidal neurons are achieved primarily through M 1 receptor activation. M 1 receptors are classically linked via G q and phospholipase C activation to the generation of two important signaling molecules: IP 3 (the endogenous ligand for IP 3 receptors) and diacylglycerol (DAG). DAG is an activator of protein kinase C, which can downregulate the M current (Schmitt and Meves, 1993) . DAG can also directly activate some nonspecific cation conductances (Hofmann et al., 1999) . If DAG does participate in the generation of depolarizing responses to ACh, the intrinsic bifurcation of the G q signaling cascade would explain how both hyperpolarizing and depolarizing responses result from activation of the same receptor subtype. Tonic M 1 receptor stimulation by low, nonsaturating concentrations of bath-applied carbachol may favor depolarization via generation of only a modest increase in cytosolic IP 3 that is insufficient to evoke the large calcium increases required to activate SK channels. In contrast, additional M 1 receptor activation during focal applications of higher concentrations of ACh may increase intracellular IP 3 to a level sufficient to initiate substantial calcium release from intracellular stores and subsequent SK channel activation. . C, Summary graph showing the mean minimum ISF attained during each of five ACh applications before (gray) and in eserine (black; n ϭ 9). D, Responses to ACh applications (20 ms) to a cell firing action potentials with a high ISF (mean ISF, 16.4 Hz) attained by somatic current injection (450 pA). E, Summary graph comparing initial ISFs, as well as minimum ISFs attained during the first and fifth ACh application, in control neurons (n ϭ 9) and neurons exposed to eserine (2 M; n ϭ 9; eserine data from neurons shown in B and C). Significant changes in the minimum ISF were observed only in eserine-treated neurons.
